Genitourinary symptoms and quality of life of women with breast cancer undergoing chemotherapy

ABSTRACT This study aimed to compare genitourinary symptoms and quality of life in women with breast cancer before and after chemotherapy treatment. This is a prospective and analytical study carried out with 60 women treated at a hospital in the state of Paraná. Sociodemographic data, menopausal st...

Full description

Saved in:
Bibliographic Details
Main Authors: Aniele Tomadon (Author), Jaqueline Lemos de Oliveira (Author), Isabella Queren de Oliveira (Author), Thais de Oliveira Gozzo (Author)
Format: Book
Published: Universidade de São Paulo, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_032250f572c44bb0b4ca7f9f88d08b6f
042 |a dc 
100 1 0 |a Aniele Tomadon  |e author 
700 1 0 |a Jaqueline Lemos de Oliveira  |e author 
700 1 0 |a Isabella Queren de Oliveira  |e author 
700 1 0 |a Thais de Oliveira Gozzo  |e author 
245 0 0 |a Genitourinary symptoms and quality of life of women with breast cancer undergoing chemotherapy 
260 |b Universidade de São Paulo,   |c 2023-12-01T00:00:00Z. 
500 |a 2316-9117 
500 |a 10.1590/1809-2950/e23001823en 
520 |a ABSTRACT This study aimed to compare genitourinary symptoms and quality of life in women with breast cancer before and after chemotherapy treatment. This is a prospective and analytical study carried out with 60 women treated at a hospital in the state of Paraná. Sociodemographic data, menopausal status, climacteric symptoms, quality of life, and pelvic floor strength and resistance were collected. Descriptive statistics, t-tests, Shapiro-Wilk, Cochran, Factorial Analysis of Variance for Repeated Measures and Fishers least significance difference were used for data analysis. Participants suffered genitourinary alterations, such as reduced strength and resistance of the pelvic floor muscles, urinary incontinence and vulvovaginal atrophy, regardless of the evaluated factors (type of chemotherapy, parity, and menopausal status). Therefore, greater attention and discussion by multidisciplinary health teams is necessary, as these symptoms can be reduced and managed if recognized early. 
546 |a EN 
546 |a ES 
546 |a PT 
690 |a Lower Urinary Tract Symptoms 
690 |a Quality of Life 
690 |a Breast Neoplasms 
690 |a Women's Health 
690 |a Drug-Related Side Effects and Adverse Reactions 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Fisioterapia e Pesquisa, Vol 30 (2023) 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1809-29502023000100223&tlng=pt 
787 0 |n http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1809-29502023000100223&tlng=en 
787 0 |n https://doaj.org/toc/2316-9117 
856 4 1 |u https://doaj.org/article/032250f572c44bb0b4ca7f9f88d08b6f  |z Connect to this object online.